Cellular apoptosis is associated with increased caveolin-1 expression in macrophages

Journal of Lipid Research

Volumn 44, Issue 9, 2003, Pages 1622-1632

  Gargalovic, Peter ^a   Dory, Ladislav ^a  

^a UNIVERSITY OF NORTH TEXAS   (United States)

Author keywords

Caveolae; Lipid raft; Membrane phospholipids; Mouse; Phosphatidylserine

Indexed keywords

CAVEOLIN 1; CELL DNA; CYCLOHEXIMIDE; MEMBRANE PHOSPHOLIPID; PHOSPHATIDYLSERINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CAVEOLA; CONTROLLED STUDY; DNA DEGRADATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CASPASES; CAVEOLIN 1; CAVEOLIN 2; CAVEOLINS; CELLS, CULTURED; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; MACROPHAGES; MEMBRANE MICRODOMAINS; MICE; PROTEIN BIOSYNTHESIS; SIMVASTATIN; UP-REGULATION;

EID: 0141794280     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: 10.1194/jlr.M300140-JLR200     Document Type: Article

References (77)

1. Anderson, R. G. 1998. The caveolae membrane system. Annu. Rev. Biochem. 67: 199-225.
2. Okamoto, T., A. Schlegel, P. E. Scherer, and M. P. Lisanti. 1998. Caveolins, a family of scaffolding proteins for organizing "preassembled signaling complexes" at the plasma membrane. J. Biol. Chem. 273: 5419-5422.
3. Scherer, P. E., T. Okamoto, M. Chun, I. Nishimoto, H. F. Lodish, and M. P. Lisanti. 1996. Identification, sequence, and expression of caveolin-2 defines a caveolin gene family. Proc. Natl. Acad. Sci. USA. 93: 131-135.
4. Scherer, P. E., R. Y. Lewis, D. Volonte, J. A. Engelman, F. Galbiati, J. Couet, D. S. Kohtz, E. van Donselaar, P. Peters, and M. P. Lisanti. 1997. Cell-type and tissue-specific expression of caveolin-2. Caveolins 1 and 2 co-localize and form a stable hetero-oligomeric complex in vivo. J. Biol. Chem. 272: 29337-29346.
5. Tang, Z., P. E. Scherer, T. Okamoto, K. Song, C. Chu, D. S. Kohtz, I. Nishimoto, H. F. Lodish, and M. P. Lisanti. 1996. Molecular cloning of caveolin-3, a novel member of the caveolin gene family expressed predominantly in muscle. J. Biol. Chem. 271: 2255-2261.
6. Couet, J., M. Sargiacomo, and M. P. Lisanti. 1997. Interaction of a receptor tyrosine kinase, EGF-R, with caveolins. Caveolin binding negatively regulates tyrosine and serine/threonine kinase activities. J. Biol. Chem. 272: 30429-30438.
7. Yamamoto, M., Y. Toya, R. A. Jensen, and Y. Ishikawa. 1999. Caveolin is air inhibitor of platelet-derived growth factor receptor signaling. Exp. Cell Res. 247: 380-388.
8. Engelman, J. A., X. L. Zhang, and M. P. Lisanti. 1999. Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5′ promoter region of the caveolin-1 gene in human breast cancer cell lines. FEBS Lett. 448: 221-230.
9. Razani, B., A. Schlegel, J. Liu, and M. P. Lisanti. 2001. Caveolin-1, a putative tumour suppressor gene. Biochem. Soc. Trans. 29: 494-499.
10. Razani, B., J. A. Engelman, X. B. Wang, W. Schubert, X. L. Zhang, C. B. Marks, F. Macaluso, R. G. Russell, M. Li, R. G. Pestell, D. Di Vizio, H. Hou, Jr., B. Kneitz, G. Lagaud, G. J. Christ, W. Edelmann, and M. P. Lisanti. 2001. Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J. Biol. Chem. 276: 38121-38138.
11. Drab, M., P. Verkade, M. Elger, M. Kasper, M. Lohn, B. Lauterbach, J. Menne, C. Lindschau, F. Mende, F. C. Luft, A. Schedl, H. Haller, and T. V. Kurzchalia. 2001. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science. 293: 2449-2452.
12. Zundel, W., L. M. Swiersz, and A. Giaccia. 2000. Caveolin 1-mediated regulation of receptor tyrosine kinase-associated phosphatidylinositol 3-kinase activity by ceramide. Mol. Cell. Biol. 20: 1507-1514.
13. Liu, J., P. Lee, F. Galbiati, R. N. Kitsis, and M. P. Lisanti. 2001. Caveolin-1 expression sensitizes librohlastic and epithelial cells to apoptotic stimulation. Am. J. Physiol. Cell Physiol. 280: C823-C835.
14. Nasu, Y., T. L. Timme, G. Yang, C. H. Bangma, L. Li, C. Ren, S. H. Park, M. DeLeon, J. Wang, and T. C. Thompson. 1998. Suppression of caveolin expression induces androgen sensitivity in metastatic androgen-insensitive mouse prostate cancer celIs. Nat. Med. 4: 1062-1064.
15. Li, L., G. Yang, S. Ebara, T. Satoh, Y. Nasu, T. L. Timme, C. Ren, J. Wang, S. A. Tahir, and T. C. Thompson. 2001. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells. Cancer Res. 61: 4386-4392.
16. Timme, T. L., A. Goltsov, S. Tahir, L. Li, J. Wang, C. Ren, R. N. Johnston, and T. C. Thompson. 2000. Caveolin-1 is regulated by c-myc and suppresses c-myc-induced apoptosis. Oncogene. 19: 3256-3265.
17. Hetts, S. W. 1998. To die or not to die: an overview of apoptosis and its role in disease. JAMA. 279: 300-307.
18. Ross, R. 1995. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57: 791-804.
19. Mitchinson, M. J., S. J. Hardwick, and M. R. Bennett. 1996. Cell death in atherosclerotic plaques. Curr. Opin. Lipidol. 7: 324-329.
20. Ball, R. Y., E. C. Stowers, J. H. Burton, N. R. Cary, J. N. Skepper, and M. J. Mitchinson. 1995. Evidence that the death of macrophage foam cells contributes to the lipid core of atheroma. Atherosclerosis. 114: 45-54.
21. Geng, Y. J., and P. Libhy. 1995. Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 beta-converting enzyme. Am. J. Pathol. 147: 251-266.
22. Hegyi, L., J. N. Skepper, N. R. Cary, and M. J. Mitchinson. 1996. Foam cell apoptosis and the development of the lipid core of human atherosclerosis. J. Pathol. 180: 423-429.
23. Bjorkerud, S., and B. Bjorkerud. 1996. Apoptosis is abundant in human atherosclerotic lesions, especially in inflammatory cells (macrophages and T cells), and may contribute to the accumulation of gruel and plaque instability. Am. J. Pathol. 149: 367-380.
24. Kockx, M. M., and M. W. Knaapen. 2000. The role of apoptosis in vascular disease. J. Pathol. 190: 267-280.
25. Warner, G. J., G. Stoudt, M. Bamberger, W. J. Johnson, and G. H. Rothblat. 1995. Cell toxicity induced by inhibition of acyl coenzyme A: cholesterol acyltransferase and accumulation of unesterilied cholesterol. J. Biol. Chem. 270: 5772-5778.
26. Yao, P. M., and I. Tabas. 2000. Free cholesterol loading of macrophages induces apoptosis involving the fas pathway. J. Biol. Chem. 275: 23807-23813.
27. Clare, K., S. J. Hardwick, K. L. Carpenter, N. Weeratunge, and M. J. Mitchinson. 1995. Toxicity of oxysterols to human monocyte-macrophages. Atherosclerosis. 118: 67-75.
28. Hardwick, S. J., L. Hegyi, K. Clare, N. S. Law, K. L. Carpenter, M. J. Mitchinson, and J. N. Skepper. 1996. Apoptosis in human monocyte-macrophages exposed to oxidized low density lipoprotein. J. Pathol. 179: 294-302.
29. Shiratsuchi, A., S. Osada, S. Kanazawa, and Y. Nakanishi. 1998. Essential role of phosphatidylserine externalization in apoptosing cell phagocytosis by macrophages. Biochem. Biophys. Res. Commun. 246: 549-555.
30. Verhoven, B., R. A. Schlegel, and P. Williamson. 1995. Mechanisms of pbosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J. Exp. Med. 182: 1597-1601.
31. Pike, L. J., X. Han, K. N. Chung, and R. W. Gross. 2002. Lipid rafts are enriched in arachidonic acid and plasmenylethanolamine and their composition is independent of caveolin-1 expression: a quantitative electrospray ionization/mass spectrometric analysis. Biochemistry. 41: 2075-2088.
32. Kunzelmann-Marche, C., J. M. Freyssinet, and M. C. Martinez. 2002. Loss of plasma membrane phospholipid asymmetry requires raft integrity. Role of transient receptor potential channels and ERK pathway. J. Biol. Chem. 277: 19876-19881.
33. Tepper, A. D., P. Ruurs, T Wiedmer, P. J. Sims, J. Borst, and W. J. van Blitterswijk. 2000. Sphingomyelin hydrolysis to ceramide during the execution phase of apoptosis results from phospholipid scrambling and alters cell-surface morphology. J. Cell Biol. 150: 155-164.
34. Gargalovic, P., and L. Dory. 2001. Caveolin-1 and caveolin-2 expression in mouse macrophages. High density lipoprotein 3-stimulated secretion and a lack of significant subcellular co-localization. J. Biol. Chem. 276: 26164-26170.
35. Lei, M. G., and D. C. Morrison. 2000. Differential expression of caveolin-1 in lipopolysaccharide-activated murine macrophages. Infect. Immun. 68: 5084-5089.
36. Baorto, D. M., Z. Gao, R. Malaviya, M. L. Dustin, A. van der Merwe, D. M. Lublin, and S. N. Abraham. 1997. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature. 389: 636-639.
37. Dory, L. 1989. Synthesis and secretion of apoE in thioglycolate-elicited mouse peritoneal macrophages: effect of cholesterol efflux. J. Lipid Res. 30: 809-816.
38. Roy, S., and D. W. Nicholson. 2000. Criteria for identifying authentic caspase substrates during apoptosis. Methods Enzymol. 322: 110-125.
39. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227: 680-685.
40. Machleidt, T., W. P. Li, P. Liu, and R. G. Anderson. 2000. Multiple domains in caveolin-1 control its intracellular traffic. J. Cell Biol. 148: 17-28.
41. Liu, P., and R. G. Anderson. 1995. Compartmentalized production of ceramide at the cell surface. J. Biol. Chem. 270: 27179-27185.
42. Hailstones, D., L. S. Sleer, R. G. Parton, and K. K. Stanley. 1998. Regulation of caveolin and caveolae by cholesterol in MDCK cells. J. Lipid Res. 39: 369-379.
43. Blanco-Colio, L. M., A. Villa, M. Ortego, M. A. Hernandez-Presa, A. Pascual J. J. Plaza, and J. Egido. 2002. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. Atherosclerosis. 161: 17-26.
44. El-Ani, D., and R. Zimlichman. 2001. Simvastatin induces apoptosis of cultured rat cardiomyocytes. J. Basic Clin. Physiol. Pharmacol. 12: 325-338.
45. Zhang, G., V. Gurtu, S. R. Kain, and G. Yan. 1997. Early detection of apoptosis using a fluorescent conjugate of annexin V. Biotechniques. 23: 525-531.
46. Fadok, V. A., D. R. Voelker, P. A. Campbell, J. J. Cohen, D. L. Bratton, and P. M. Henson, 1992. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148: 2207-2216.
47. Albina, J. E., S. Cui, R. B. Mateo, and J. S. Reichner. 1993. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol. 150: 5080-5085.
48. Onishi, Y., Y. Azuma, Y. Sato, Y. Mizuno, T. Tadakuma, and H. Kizaki. 1993. Topoisomerase inhibitors induce apoptosis in thymocytes. Biochim. Biophys. Acta. 1175: 147-154.
49. Earnshaw, W. C., L. M. Martins, and S. H. Kaufmann. 1999. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu. Rev. Biochem. 68: 388-424.
50. Gargalovic, P., and L. Dory. 2003. Caveolins and macrophage lipid metabolism. J. Lipid Res. 44: 11-21.
51. Dory, L. 1991. Regulation of apolipoprotein E secretion by high density lipoprotein 3 in mouse macrophages. J. Lipid Res. 32: 783-792.
52. Lewis, J. G., D. O. Adams, and S. Fan. 1995. Selective sensitivity of macrophages to cytotoxicity by inhibitors of macromolecular synthesis: induction of apoptosis. J. Leukoc. Biol. 57: 635-642.
53. Engelman, J. A., C. C. Wykoff, S. Yasuhara, K. S. Song, T. Okamoto, and M. P. Lisami. 1997. Recombinant expression of caveolin-1 in oncogenically transformed cells abrogates anchorage-independent growth. J. Biol. Chem. 272: 16374-16381.
54. Koleske, A. J., D. Baltimore, and M. P. Lisanti. 1995. Reduction of caveolin and caveolae in oncogenically transformed cells. Proc. Natl. Acad. Sci. USA. 92: 1381-1385.
55. Lee, S. W., C. L. Reimer, P. Oh, D. B. Campbell, and J. E. Schnitzer. 1998. Tumor cell growth inhibition by caveolin re-expression in human breast cancer cells. Oncogene. 16: 1391-1397.
56. Racine, C., M. Belanger, H. Hirahayashi, M. Boucher, J. Chakir, and J. Couet. 1999. Reduction of caveolin 1 gene expression in lung carcinoma cell lines. Biochem. Biophys. Res. Commun. 255: 580-586.
57. Tahir, S. A., G. Yang, S. Ebara, T. L. Timme, T. Satoh, L. Li, A. Goltsov, M. Ittmann, J. D. Morrisett, and T. C. Thompson. 2001. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res. 61: 3882-3885.
58. Giroux, L. M., J. Davignon, and M. Naruszewicz. 1993. Simvastatin inhibits the oxidation of low-density lipoproteins by activated human monocyte-derived macrophages. Biochim. Biophys. Acta. 1165: 335-338.
59. Pentikainen, P. J., M. Saraheimo, J. I. Schwartz, R. D. Amin, M. S. Schwartz, F. Brunner-Ferber, and J. D. Rogers. 1992. Comparative pharmacokinetics of lovastatin, simvastatin and pravastatin in humans. J. Clin. Pharmacol. 32: 136-140.
60. Guijarro, C., L. M. Blanco-Colio, M. Ortego, C. Alonso, A. Ortiz, J. J. Plaza, C. Diaz, G. Hernandez, and J. Egido. 1998. 3-Hydroxy-3-methylglutaryl coenzyme a reductase and isoprenylation inhibitors induce apoptosis of vascular smooth muscle cells in culture. Circ. Res. 83: 490-500.
61. Rothenherg, M. L. 1997. Topoisomerase 1 inhibitors: review and update. Ann. Oncol. 8: 837-855.
62. Singhal, P. C., K. Reddy, G. Ding, A. Kapasi, N. Franki, R. Ranjan, I. E. Nwakoby, and N. Gibbons. 1999. Ethanol-induced macrophage apoptosis: the role of TGF-beta. J. Immunol. 162: 3031-3036.
63. McIlroy, D., H. Sakahira, R. V. Talanian, and S. Nagata. 1999. Involvement of caspase 3-activated DNase in internucleosomal DNA cleavage induced by diverse apoptotic stimuli. Oncogene. 18: 4401-4408.
64. Inayat-Hussain, S. H., S. L. Winski, and D. Ross. 2001. Differential involvement of caspases in hydroquinone-induced apoptosis in human leukemic hl-60 and jurkat cells. Toxicol. Appl. Pharmacol. 175: 95-103.
65. Chi, S., C. Kitanaka, K. Noguchi, T. Mochizuki, Y. Nagashima, M. Shirouzu, H. Fujita, M. Yoshida, W. Chen, A. Asai, M. Himeno, S. Yokoyama, and Y. Kuchino. 1999. Oncogenic Ras triggers cell suicide through the activation of a caspase-independent cell death program in human cancer cell. Oncogene. 18: 2281-2290.
66. Kawahara, A., Y. Ohsawa, H. Matsumura, Y. Uchiyima, and S. Nagata. 1998. Caspase-independent cell killing by Fas-associated protein with death domain. J. Cell Biol. 143: 1353-1360.
67. Lavoie, J. N., M. Nguyen, R. C. Marcellus, P. E. Branton, and G. C. Shore. 1998. E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk. J. Cell Biol. 140: 637-645.
68. Mateo, V., L. Lagneaux, D. Bron, G. Biron, M. Armant, G. Delespesse, and M. Sarfati. 1999. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia. Nat. Med. 5: 1277-1284.
69. Huigsloot, M., I. B. Tijdens, G. J. Mulder, and B. van de Water. 2001. Differential regulation of phosphatidylserine externalization and DNA fragmentation by caspases in anticancer drug-induced apoptosis of rat mammary adenocarcinoma MTLn3 cells. Biochem. Pharmacol. 62: 1087-1097.
70. Zhuang, J., Y. Ren, R. T. Snowden, H. Zhu, V. Gogvadze, J. S. Savill, and G. M. Cohen. 1998. Dissociation of phagocyte recognition of cells undergoing apoptosis from other features of the apoptotic program. J. Biol. Chem. 273: 15628-15632.
71. Machaca, K., and M. M. Compton. 1992. Characterization of apoptosis-like endonuclease activity in avian thymocytes. Biol. Cell. 76: 15-22.
72. Mogil, R. J., Y. Shi, R. P. Bissonnette, P. Bromley, I. Yamaguchi, and D. R. Green. 1994. Role of DNA fragmentation in T cell activation-induced apoptosis in vitro and in vivo. J. Immunol. 152: 1674-1683.
73. Verhoven, B., S. Krahling, R. A. Schlegel, and P. Williamson. 1999. Regulation of phosphatidylserine exposure and phagocytosis of apoptotic T lymphocytes. Cell Death Differ. 6: 262-270.
74. Bratton, D. L., V. A. Fadok, D. A. Richter, J. M. Kailey, L. A. Guthrie, and P. M. Henson. 1997. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J. Biol. Chem. 272: 26159-26165.
75. Zhao, J., Q. Zhou, T. Wiedmer, and P. J. Sims. 1998. Level of expression of phospholipid scramblase regulates induced movement of phosphatidylserine to the cell surface. J. Biol. Chem. 273: 6603-6606.
76. Siegmund, A., A. Grant, C. Angeletti, L. Malone, J. W. Nichols, and H. K. Rudolph. 1998. Loss of Drs2p does not abolish transfer of fluorescence-labeled phospholipids across the plasma membrane of Saccharomyces cerevisiae. J. Biol. Chem. 273: 34399-34405.
77. Zhou, Q., J. Zhao, T. Wiedmer, and P. J. Sims. 2002. Normal hemostasis but defective hematopoietic response to growth factors in mice deficient in phospholipid scramblase 1. Blood. 99: 4030-4038.